Literature DB >> 1526055

Nasal mucosal involvement in lupus erythematosus.

A K Robson1, S M Burge, P R Millard.   

Abstract

The involvement of oral, conjunctival and genital mucosa in lupus erythematosus (LE) has recently been described. Reports of nasal involvement have been sporadic. A prospective study was performed to assess the prevalence of nasal symptoms and signs in LE and to identify the incidence of deposition of immunoreactants in the nasal mucosa of patients with LE. Thirty-six patients with LE were studied; 21 had non-specific nasal symptoms and 12 had evidence of chronic inflammatory changes in the mucosa of the nasal cavity or in the vestibule (septal perforation, inflamed mucosa, vestibulitis). Immunoreactants were found in only 4 patients and did not correlate well with clinical evidence of disease. Nasal mucosal involvement in LE is underestimated and often overlooked in the assessment of such patients.

Entities:  

Mesh:

Year:  1992        PMID: 1526055     DOI: 10.1111/j.1365-2273.1992.tb01009.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  4 in total

Review 1.  Nasal manifestations of systemic illnesses.

Authors:  Isam Alobid; Jose Maria Guilemany; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2004-05       Impact factor: 4.806

2.  Nasal vestibulitis due to targeted therapies in cancer patients.

Authors:  Janelle N Ruiz; Viswanath Reddy Belum; Christine B Boers-Doets; Mini Kamboj; N Esther Babady; Yi-Wei Tang; Tulio A Valdez; Mario E Lacouture
Journal:  Support Care Cancer       Date:  2015-01-22       Impact factor: 3.603

3.  Evaluation of olfactory function in Behçet's disease.

Authors:  Lütfi Akyol; Emre Günbey; Rıfat Karlı; Soner Önem; Metin Özgen; Mehmet Sayarlıoğlu
Journal:  Eur J Rheumatol       Date:  2016-12-01

4.  Autoimmune-related nasal septum perforation: A case report and systematic review.

Authors:  Lohitha Guntupalli; Kunjan Patel; Farhoud Faraji; Joseph D Brunworth
Journal:  Allergy Rhinol (Providence)       Date:  2017-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.